Author | Douglas B. Johnson, MD, MSCI

Articles

Immune Checkpoint Inhibitor Therapy in Patients With Autoimmune Disease

April 15, 2018

ByDouglas B. Johnson, MD, MSCI|Kathryn E. Beckermann, MD, PhD|Daniel Y. Wang, MD

In this article, we detail the experience with immune checkpoint inhibitors in patients with autoimmune disease.

Combination Immunotherapy: An Emerging Paradigm in Cancer Therapeutics

December 15, 2015

ByDaniel Y. Wang, MD|Jeffrey A. Sosman, MD|Douglas B. Johnson, MD, MSCI

In view of the potential for durable responses with immunotherapy, it will be important to identify the most effective and least toxic regimens for individual patients.